Cancer BiologybioRxivPreprint
Synergistic targeting of MCL1 and caspases for enhanced anti-tumor immunity in breast cancer.
Jae Kyo Yi, Jisun Lee, Pilhan Kim…·Alexander Spektor
This study shows that combining MCL1 and caspase inhibition enhances anti-tumor immunity in breast cancer by activating the cGAS-STING pathway and remodeling the tumor microenvironment.
DOI 10.1101/2025.10.10.681458